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Malaria, the number one disease in the world, is caused by
intracellular protozoans belonging to the Subphylum, Sporozoa;
Suborder, Haemosphoridia; and Family, Plasmodiidae. The four
classical organisms producing disease in man are Plasmodium vivax,
P. falciparum, P. malariae, and P. ovale. Although malaria has been
known to man for centuries, attempts are still being made to control
and eliminate its devastating effects in tropical and subtropical areas
of the world. Current active interest in malarial immunology and
immunopathology derives from two main facts: (1) that human
malaria is still one of the chief health problems in a broad tropical
and subtropical zone in which lie most of the developing countries;
and (2) most of the seminal leads in basic immunology are being
applied to malarial immunology, either directly in human patients, or
using laboratory animals as test objects.
This paper addresses the nature of malarial immunity and target
organs in malarial pathology.
Plasmodia consists of an array of
heterogenous antigenic components
whose molecular weights range between 60,000 and 90,000 for human
plasmodia, from 8,000 to 130,000 for
rodent plasmodia, and may reach
700,000 for avian plasmodia. 13 Some of
the antigens are proteins, glycoproteins, or membrane-associated phospholipids.
More than 30 distinct antigens have
been identified in association with the
blood forms of P. falciparum and antibodies of corresponding specificity
have been detected in sera obtained
from Gambian residents in hyperendemic areas. Wilson et a14 have
classified these antigens into three main
groups: L (labile), R (resistant), and S
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(stable) on the basis of their ability to
withstand heating, and have further divided these classes into subgroups on
the basis of other factors (La' and La2,
Lb, R1, and R2, S1 and S2). Not all antigens of P. falciparum are equally immunogenic. La antigens appear to be good
immunogens since antibodies to them
can be demonstrated, in high titre, in
sera taken from all age groups in hyperendemic areas.5 On the other hand, S
antigens often failed to induce a detectable antibody response in heavily
parasitized children, and when responses did occur they were weak and
transient.6 In more recent studies, the
gel diffusion test was used to detect antibodies to malarial S antigens in sera of
young Gambian children. Antibodies
tended to appear more swiftly when
antigen was lost rapidly from the circulation. Observations made on individual responses indicated antibody
production was influenced by factors
other than the intrinsic properties of
antigens, such as genetic ability to respond, immunological competence,
and malarial experience.47 RI antigen
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has been identified in all extracts of P.
falciparum parasites examined by Wilson and his colleagues,4 yet antibodies
to them have been found in only one of
thousands of immune sera studied.
Plasmodial antigens at the surface of
the infected erythrocyte8 or of the
parasite9 are suspected of being strain
specific, and therefore possibly of
being associated with strain specific
protection. In addition to blood stage
antigens, stage-specific sporozoite antigens exist and have been investigated.10'11 The fact that only mature
sporozoites are highly infective
suggests a possible relationship between antigen and infectivity. Stage of
maturation and antigenic modulation in
response to antibody may contribute to
the antigenic variability of Plasmodium. 12
According to the studies of Mitchell
et al,13 stage specific antigens associated with merozoites are vulnerable to neutralizing antibody, which is
thought to interfere with the attachment of merozoites to specific receptor
sites on susceptible erythrocytes.
Since plasmodia consist of numerous antigens, it is to be expected they
would induce multiple antibody reactions. With the aid of radial immunodiffusion in agar and comparative immunoelectrophoresis, both employing
antibody raised against specific immunoglobin (Ig) categories, the dynamic changes in serum Ig levels can be
followed. 14,15
Ig production increase is manifold
during malarial infection, but much of
the Ig produced is not antiplasmodial
antibody, and little of the specific antibody protective.16 In the sera studied,
protective antibody was associated
with both IgG and IgM, but not with
IgA or IgE. Antiplasmodial protection
in human malaria is generally association with raised levels of IgG.17 Population studies in Gambia have shown
349

malarial parasitemia to be associated
with elevated levels of IgG over the
first 20 years of life, but with elevated
IgM levels over only the first two
years.6
The factors that determine the Ig
class of antibodies synthesized are not
known, but age, immunocompetence,
and previous exposure are probably
important.2'3

Course of Infection
According to Voller,18 under natural
conditions malaria infections are initiated when an infected mosquito injects sporozoites as it feeds. The
sporozoites circulate for only a few
minutes before becoming localized in
the liver, where development of preand exoerythrocytic forms take place.
There seems to be no immunological
response to the injected viable sporozoites under natural conditions. This is
rather surprising as it has been shown
that injected sporozoites, modified by
radiation or chemical treatment, can
lead to serological response and to the
development of immunity to subsequent challenge by viable sporo-

sulting from phagocytic activity.5'2' The
phagocytosis is not just an increase in
the nonspecific activity of macrophages, but a specific immunological
process. The immunological processes
involved opsonization, agglutination,
and precipitation reactions.5'22'23
Synergism between cells and antibody is suggested in immune mechanisms against malarial asexual cycles
(merozoites) in the blood,'2 with primary mediation by specific IgG antibodies.6 Complement is frequently involved in the process.24 According to
Cohen et al,'6 cell-mediated immunity
has no defined role in specific malarial
immunity. Under natural conditions
survival of parasites in the immunized
host (acquired immunity) is related to
reinfection with distinct strains of the
species or represents a relapse derived
from persistent pre-erythrocytic stages
of the Plasmodium. It may also be related to soluble immune complexes or
free antigens blocking the action of the
antibody, or be connected with the organism's ability to undergo antigenic
variation.24

zoites.11"19

Immunopathology

Pre- and exoerythrocytic forms developing in the liver seem to evoke no
immunological response until they
reach maturity. Voller'8 reported that
at the time of rupture of the tissue
schizont, polymorphonuclear leukocytes invade the site, followed by other
cellular infiltrates, which decline in a
short time. No serum antibodies are detectable at the time. It is only when invasion of the blood occurs that the full
immunopathological response is initiated. Each asexual cycle of
parasitemia consists of trophozoites
forming schizonts, each containing
merozoites which are released on rupture of the host cell to infect more red
cells.20
In most malaria infections, the
theoretical rate of multiplication is
rarely reached due to removal of the
parasites and infected cells by
phagocytic activities in the spleen. The
parasitemia increases up to a certain
point then decreases abruptly. The point
where the host's defenses gain control
is known as the crisis and leads to the
drop in parasitaemia. Crisis is characterized by intense reticuloendothelial
hyperplasia and reactivity, with many
of the macrophages being loaded with
malarial pigment and other products re-

McGregor2 finds that malaria often
elicits serological responses which, in
temperate zones, are usually associated
with connective-tissue disease. This
may be due to (a) release of crossreacting antigen or (b) alteration of host
tissue, thus rendering it antigenic. In
either case, Mathews et a125 postulate
that this leads to production of antibodies which react with their substrates.
The majority of all sera of adults in
malarious areas contain heterophile
agglutinins of IgM class that react with
foreign erythrocytes in vitro, or even
with trypsinized human erythrocytes.
Rheumatoid factor, an antiglobulin,
usually to IgG, is also common in
malarious areas and the titres in adults
often correlate with their malarial antibody levels.26.27
The first hint that malaria might affect the immune response to unrelated
antigens was provided by McGregor,6
who showed that malaria-Infected persons responded less well to tetanus toxoid infections. Greenwood et a127 pursued this and found that some humoral
but not cell-mediated responses were
depressed and that the depression was
greatest in those individuals with high
parasitemia. Targett28 has put forward a
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theory that trypanosome infections
may interfere with the cooperation of
T- and B-lymphocytes and also lead to
excessive production of partially
nonspecific IgM and to immunodepression of other immune responses that
require T- and B-cell cooperation. Topley et a129 believe that malarial immunosuppression is basically due to the
same mechanism as postulated for
trypanosomiasis.
Malarial immunodepression has received much attention recently in the
context of what it might mean in terms
of other diseases. Greenwood et a127
speculated that the apparent rarity of
some autoimmune diseases in the
tropics might be related to immunological disturbances produced by malaria.
Support for this point of view has come
from experimental work in which it was
shown that some diseases, thought to
be of autoimmune origin, which occur
spontaneously in some strains of mice,
could be delayed by infecting the animals with malarial organisms.
Of particular interest in the immunopathological sense is what a variety of authors have considered to be an
identifiable entity and have termed the
"tropical splenomegaly syndrome" or
"big spleen disease," and which they
consider to be associated with

malaria.27'30
An apparently identical disease has
been reported from areas of East and
West Africa, India, and New Guinea
where malaria is endemic.27 It is
claimed that this is a discrete syndrome, the characteristics of which include massive chronic splenomegaly
associated with lymphocytic infiltration
of hepatic sinusoids and high serum
levels of IgM and malarial antibodies.
Affected individuals, although often living in areas of highly edemic malaria,
do not have higher than usual parasite
rates or densities, but long-term antimalarial therapy does lead to a reduction in their spleen size.3' It has been
suggested that patients with tropical
splenomegaly syndrome have an aberrant, although effective, immune response to malaria. The sera of these
patients contain large amounts of IgM
in addition to high levels of antiglobulins and hemagglutinins.27,30
It is probable that more immunopathological sequels to malaria,
combined with other agents, will be
identified in the future. It is well
known, too, that accidental contamination of animal malaria parasite
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strains with viruses eperythrozoon,
Haemobartonella, or Mycoplasma can
easily occur and the course of a malaria
infection and its pathology can then be
altered.32
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1979 NMA Convention
The 84th annual convention and
scientific assembly of the
National Medical Association
will be held in Detroit, Michigan
from July 29-August 2, 1979.
The scientific program will include
Aerospace and Military Medicine,
Anesthesiology, Basic Science,
Community Medicine, Dermatology,
Family Practice, Internal Medicine,
Neurology and Psychiatry,
Obstetrics and Gynecology,

Ophthalmology, Orthopedics,
Otolaryngology, Pediatrics,
Physical Medicine and Rehabilitation,
Radiology, Surgery, and Urology.
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